 | • レポートコード：MRC2-11QY10918 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は萎縮性胃炎治療のグローバル市場について調査・分析したレポートです。種類別（コーティング剤、抗生物質、ビタミンB-12）市場規模、用途別（病院薬局、小売薬局、ドラッグストア、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別萎縮性胃炎治療の競争状況、市場シェア ・世界の萎縮性胃炎治療市場：種類別市場規模 2015年-2020年（コーティング剤、抗生物質、ビタミンB-12） ・世界の萎縮性胃炎治療市場：種類別市場規模予測 2021年-2026年（コーティング剤、抗生物質、ビタミンB-12） ・世界の萎縮性胃炎治療市場：用途別市場規模 2015年-2020年（病院薬局、小売薬局、ドラッグストア、オンライン薬局） ・世界の萎縮性胃炎治療市場：用途別市場規模予測 2021年-2026年（病院薬局、小売薬局、ドラッグストア、オンライン薬局） ・北米の萎縮性胃炎治療市場分析：米国、カナダ ・ヨーロッパの萎縮性胃炎治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの萎縮性胃炎治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の萎縮性胃炎治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの萎縮性胃炎治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Takeda Pharmaceutical Company Limited、PERNIX Therapeutics、Perrigo Pharmaceutical、Teva Pharmaceutical ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Atopic gastritis is chronic inflammation of gastric mucosa, and it is a histopathological condition associated with gastric glandular cell and replacement by fibrous tissue, intestinal type epithelium, and pyloric type glands. It mainly associated H. Pylori bacterial infection, and autoimmunity directed against gastric glandular cell. Symptoms include stomach pain, loss of appetite, nausea, unexpected weight loss, iron deficiency anemia. There is a high chance for the development of pernicious anemia in autoimmune atrophic gastritis Individual due to the loss of anti-intrinsic antibodies and parietal cell mass. Atrophic gastritis associated with H. Pylori are at high risk of developing gastric carcinoma and is frequently asymptomatic. Individuals associated with chronic atrophic gastritis develop hypergastrinemia and low gastric acid output which may lead to carcinoid tumors and enterochromaffin-like cell hyperplasia. Atrophic gastritis develops at childhood and if, it is left untreated atrophic gastritis progress throughout the lifespan. Treatment mainly includes antibiotics for eliminating H. Pylori bacteria. Symptomatic treatment includes vitamin B-12 injections. Proton pump inhibitors used to control the acidity of the stomach. Autoimmune atrophic gastritis associated with gastric polyps, pernicious anemia, and adenocarcinoma. Atrophic gastritis diagnosed by low levels of B-12, low levels of pepsinogen, high levels of gastrin and intrinsic factors.
Atrophic gastritis is associated with loss of gastric gland and is a progressive condition with the replacement of metaplasia. It is asymptomatic and associated with large complications like gastric carcinoma, hyperplasia, hypergastrinemia, increased risk of heart attack in elderly. The frequency of atrophic gastritis is unknown due to it is mostly asymptomatic. Atrophic gastritis is extremely common and is highly prevalent in different parts of the globe. In atrophic gastritis, eradication of H. Pylori is highly complicated, and it requires follow-up for several years. Eradication of H. Pylori reduces the risk of developing cancers in late stages. Mortality and morbidity associated with atrophic gastritis are depended on underlying complications of diseases. Atrophic gastritis requires a continuous management because recurrence of illness is high. All these factors act as a driver in the robust growth of the atrophic gastritis treatment market.
Market Analysis and Insights: Global Atrophic Gastritis Treatment Market
The global Atrophic Gastritis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Atrophic Gastritis Treatment Scope and Market Size
Atrophic Gastritis Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Atrophic Gastritis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Takeda Pharmaceutical Company Limited
PERNIX Therapeutics
Perrigo Pharmaceutical
Teva Pharmaceutical
…
Market segment by Type, the product can be split into
Coating Agents
Antibiotics
Vitamin B-12
Market segment by Application, split into
Hospital Pharmacies
Retail Pharmacies
Drug Stores
Online Pharmacies
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Atrophic Gastritis Treatment Revenue
1.4 Market by Type
1.4.1 Global Atrophic Gastritis Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Coating Agents
1.4.3 Antibiotics
1.4.4 Vitamin B-12
1.5 Market by Application
1.5.1 Global Atrophic Gastritis Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Drug Stores
1.5.5 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Atrophic Gastritis Treatment Market Perspective (2015-2026)
2.2 Global Atrophic Gastritis Treatment Growth Trends by Regions
2.2.1 Atrophic Gastritis Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Atrophic Gastritis Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Atrophic Gastritis Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Atrophic Gastritis Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Atrophic Gastritis Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Atrophic Gastritis Treatment Players by Market Size
3.1.1 Global Top Atrophic Gastritis Treatment Players by Revenue (2015-2020)
3.1.2 Global Atrophic Gastritis Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Atrophic Gastritis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Atrophic Gastritis Treatment Market Concentration Ratio
3.2.1 Global Atrophic Gastritis Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Atrophic Gastritis Treatment Revenue in 2019
3.3 Atrophic Gastritis Treatment Key Players Head office and Area Served
3.4 Key Players Atrophic Gastritis Treatment Product Solution and Service
3.5 Date of Enter into Atrophic Gastritis Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Atrophic Gastritis Treatment Historic Market Size by Type (2015-2020)
4.2 Global Atrophic Gastritis Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Atrophic Gastritis Treatment Market Size by Application (2015-2020)
5.2 Global Atrophic Gastritis Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Atrophic Gastritis Treatment Market Size (2015-2020)
6.2 Atrophic Gastritis Treatment Key Players in North America (2019-2020)
6.3 North America Atrophic Gastritis Treatment Market Size by Type (2015-2020)
6.4 North America Atrophic Gastritis Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Atrophic Gastritis Treatment Market Size (2015-2020)
7.2 Atrophic Gastritis Treatment Key Players in Europe (2019-2020)
7.3 Europe Atrophic Gastritis Treatment Market Size by Type (2015-2020)
7.4 Europe Atrophic Gastritis Treatment Market Size by Application (2015-2020)
8 China
8.1 China Atrophic Gastritis Treatment Market Size (2015-2020)
8.2 Atrophic Gastritis Treatment Key Players in China (2019-2020)
8.3 China Atrophic Gastritis Treatment Market Size by Type (2015-2020)
8.4 China Atrophic Gastritis Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Atrophic Gastritis Treatment Market Size (2015-2020)
9.2 Atrophic Gastritis Treatment Key Players in Japan (2019-2020)
9.3 Japan Atrophic Gastritis Treatment Market Size by Type (2015-2020)
9.4 Japan Atrophic Gastritis Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Atrophic Gastritis Treatment Market Size (2015-2020)
10.2 Atrophic Gastritis Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Atrophic Gastritis Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Atrophic Gastritis Treatment Market Size by Application (2015-2020)
11 India
11.1 India Atrophic Gastritis Treatment Market Size (2015-2020)
11.2 Atrophic Gastritis Treatment Key Players in India (2019-2020)
11.3 India Atrophic Gastritis Treatment Market Size by Type (2015-2020)
11.4 India Atrophic Gastritis Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Atrophic Gastritis Treatment Market Size (2015-2020)
12.2 Atrophic Gastritis Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Atrophic Gastritis Treatment Market Size by Type (2015-2020)
12.4 Central & South America Atrophic Gastritis Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Takeda Pharmaceutical Company Limited
13.1.1 Takeda Pharmaceutical Company Limited Company Details
13.1.2 Takeda Pharmaceutical Company Limited Business Overview
13.1.3 Takeda Pharmaceutical Company Limited Atrophic Gastritis Treatment Introduction
13.1.4 Takeda Pharmaceutical Company Limited Revenue in Atrophic Gastritis Treatment Business (2015-2020))
13.1.5 Takeda Pharmaceutical Company Limited Recent Development
13.2 PERNIX Therapeutics
13.2.1 PERNIX Therapeutics Company Details
13.2.2 PERNIX Therapeutics Business Overview
13.2.3 PERNIX Therapeutics Atrophic Gastritis Treatment Introduction
13.2.4 PERNIX Therapeutics Revenue in Atrophic Gastritis Treatment Business (2015-2020)
13.2.5 PERNIX Therapeutics Recent Development
13.3 Perrigo Pharmaceutical
13.3.1 Perrigo Pharmaceutical Company Details
13.3.2 Perrigo Pharmaceutical Business Overview
13.3.3 Perrigo Pharmaceutical Atrophic Gastritis Treatment Introduction
13.3.4 Perrigo Pharmaceutical Revenue in Atrophic Gastritis Treatment Business (2015-2020)
13.3.5 Perrigo Pharmaceutical Recent Development
13.4 Teva Pharmaceutical
13.4.1 Teva Pharmaceutical Company Details
13.4.2 Teva Pharmaceutical Business Overview
13.4.3 Teva Pharmaceutical Atrophic Gastritis Treatment Introduction
13.4.4 Teva Pharmaceutical Revenue in Atrophic Gastritis Treatment Business (2015-2020)
13.4.5 Teva Pharmaceutical Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Atrophic Gastritis Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Atrophic Gastritis Treatment Revenue
Table 3. Ranking of Global Top Atrophic Gastritis Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Atrophic Gastritis Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Coating Agents
Table 6. Key Players of Antibiotics
Table 7. Key Players of Vitamin B-12
Table 8. Global Atrophic Gastritis Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Atrophic Gastritis Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Atrophic Gastritis Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Atrophic Gastritis Treatment Market Share by Regions (2015-2020)
Table 12. Global Atrophic Gastritis Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Atrophic Gastritis Treatment Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Atrophic Gastritis Treatment Market Growth Strategy
Table 18. Main Points Interviewed from Key Atrophic Gastritis Treatment Players
Table 19. Global Atrophic Gastritis Treatment Revenue by Players (2015-2020) (Million US$)
Table 20. Global Atrophic Gastritis Treatment Market Share by Players (2015-2020)
Table 21. Global Top Atrophic Gastritis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Atrophic Gastritis Treatment as of 2019)
Table 22. Global Atrophic Gastritis Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Atrophic Gastritis Treatment Product Solution and Service
Table 25. Date of Enter into Atrophic Gastritis Treatment Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Atrophic Gastritis Treatment Market Size by Type (2015-2020) (Million US$)
Table 28. Global Atrophic Gastritis Treatment Market Size Share by Type (2015-2020)
Table 29. Global Atrophic Gastritis Treatment Revenue Market Share by Type (2021-2026)
Table 30. Global Atrophic Gastritis Treatment Market Size Share by Application (2015-2020)
Table 31. Global Atrophic Gastritis Treatment Market Size by Application (2015-2020) (Million US$)
Table 32. Global Atrophic Gastritis Treatment Market Size Share by Application (2021-2026)
Table 33. North America Key Players Atrophic Gastritis Treatment Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Atrophic Gastritis Treatment Market Share (2019-2020)
Table 35. North America Atrophic Gastritis Treatment Market Size by Type (2015-2020) (Million US$)
Table 36. North America Atrophic Gastritis Treatment Market Share by Type (2015-2020)
Table 37. North America Atrophic Gastritis Treatment Market Size by Application (2015-2020) (Million US$)
Table 38. North America Atrophic Gastritis Treatment Market Share by Application (2015-2020)
Table 39. Europe Key Players Atrophic Gastritis Treatment Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Atrophic Gastritis Treatment Market Share (2019-2020)
Table 41. Europe Atrophic Gastritis Treatment Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Atrophic Gastritis Treatment Market Share by Type (2015-2020)
Table 43. Europe Atrophic Gastritis Treatment Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Atrophic Gastritis Treatment Market Share by Application (2015-2020)
Table 45. China Key Players Atrophic Gastritis Treatment Revenue (2019-2020) (Million US$)
Table 46. China Key Players Atrophic Gastritis Treatment Market Share (2019-2020)
Table 47. China Atrophic Gastritis Treatment Market Size by Type (2015-2020) (Million US$)
Table 48. China Atrophic Gastritis Treatment Market Share by Type (2015-2020)
Table 49. China Atrophic Gastritis Treatment Market Size by Application (2015-2020) (Million US$)
Table 50. China Atrophic Gastritis Treatment Market Share by Application (2015-2020)
Table 51. Japan Key Players Atrophic Gastritis Treatment Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Atrophic Gastritis Treatment Market Share (2019-2020)
Table 53. Japan Atrophic Gastritis Treatment Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Atrophic Gastritis Treatment Market Share by Type (2015-2020)
Table 55. Japan Atrophic Gastritis Treatment Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Atrophic Gastritis Treatment Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Atrophic Gastritis Treatment Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Atrophic Gastritis Treatment Market Share (2019-2020)
Table 59. Southeast Asia Atrophic Gastritis Treatment Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Atrophic Gastritis Treatment Market Share by Type (2015-2020)
Table 61. Southeast Asia Atrophic Gastritis Treatment Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Atrophic Gastritis Treatment Market Share by Application (2015-2020)
Table 63. India Key Players Atrophic Gastritis Treatment Revenue (2019-2020) (Million US$)
Table 64. India Key Players Atrophic Gastritis Treatment Market Share (2019-2020)
Table 65. India Atrophic Gastritis Treatment Market Size by Type (2015-2020) (Million US$)
Table 66. India Atrophic Gastritis Treatment Market Share by Type (2015-2020)
Table 67. India Atrophic Gastritis Treatment Market Size by Application (2015-2020) (Million US$)
Table 68. India Atrophic Gastritis Treatment Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Atrophic Gastritis Treatment Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Atrophic Gastritis Treatment Market Share (2019-2020)
Table 71. Central & South America Atrophic Gastritis Treatment Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Atrophic Gastritis Treatment Market Share by Type (2015-2020)
Table 73. Central & South America Atrophic Gastritis Treatment Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Atrophic Gastritis Treatment Market Share by Application (2015-2020)
Table 75. Takeda Pharmaceutical Company Limited Company Details
Table 76. Takeda Pharmaceutical Company Limited Business Overview
Table 77. Takeda Pharmaceutical Company Limited Product
Table 78. Takeda Pharmaceutical Company Limited Revenue in Atrophic Gastritis Treatment Business (2015-2020) (Million US$)
Table 79. Takeda Pharmaceutical Company Limited Recent Development
Table 80. PERNIX Therapeutics Company Details
Table 81. PERNIX Therapeutics Business Overview
Table 82. PERNIX Therapeutics Product
Table 83. PERNIX Therapeutics Revenue in Atrophic Gastritis Treatment Business (2015-2020) (Million US$)
Table 84. PERNIX Therapeutics Recent Development
Table 85. Perrigo Pharmaceutical Company Details
Table 86. Perrigo Pharmaceutical Business Overview
Table 87. Perrigo Pharmaceutical Product
Table 88. Perrigo Pharmaceutical Revenue in Atrophic Gastritis Treatment Business (2015-2020) (Million US$)
Table 89. Perrigo Pharmaceutical Recent Development
Table 90. Teva Pharmaceutical Company Details
Table 91. Teva Pharmaceutical Business Overview
Table 92. Teva Pharmaceutical Product
Table 93. Teva Pharmaceutical Revenue in Atrophic Gastritis Treatment Business (2015-2020) (Million US$)
Table 94. Teva Pharmaceutical Recent Development
Table 95. Research Programs/Design for This Report
Table 96. Key Data Information from Secondary Sources
Table 97. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Atrophic Gastritis Treatment Market Share by Type: 2020 VS 2026
Figure 2. Coating Agents Features
Figure 3. Antibiotics Features
Figure 4. Vitamin B-12 Features
Figure 5. Global Atrophic Gastritis Treatment Market Share by Application: 2020 VS 2026
Figure 6. Hospital Pharmacies Case Studies
Figure 7. Retail Pharmacies Case Studies
Figure 8. Drug Stores Case Studies
Figure 9. Online Pharmacies Case Studies
Figure 10. Atrophic Gastritis Treatment Report Years Considered
Figure 11. Global Atrophic Gastritis Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Atrophic Gastritis Treatment Market Share by Regions: 2020 VS 2026
Figure 13. Global Atrophic Gastritis Treatment Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Atrophic Gastritis Treatment Market Share by Players in 2019
Figure 16. Global Top Atrophic Gastritis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Atrophic Gastritis Treatment as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Atrophic Gastritis Treatment Revenue in 2019
Figure 18. North America Atrophic Gastritis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Atrophic Gastritis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Atrophic Gastritis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Atrophic Gastritis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Atrophic Gastritis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Atrophic Gastritis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Atrophic Gastritis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
胃炎治療の世界市場（～2026年） Gastritis is inflammation of the lining of the stomach. It may occur as a short episode or may be of a long duration. There may be no symptoms but, when symptoms are present, the most common is upper abdominal pain. Other possible symptoms include nausea and vomiting, bloating, loss of appetite and …- 胃炎治療薬の世界市場（～2026年） Gastritis is inflammation of the lining of the stomach. It may occur as a short episode or may be of a long duration. There may be no symptoms but, when symptoms are present, the most common is upper abdominal pain. Other possible symptoms include nausea and vomiting, bloating, loss of appetite and …
- 眼炎症治療の世界市場（～2026年） Eye inflammations or uveitis are becoming a common problem for people across global geographies. New drugs are being discovered to treat ocular inflammations, and companies are investing millions for their approval through regulatory pipelines. Patients are exhibiting a particular preference to the …
- クッシング病治療の世界市場（～2026年） Cushing disease is caused by tumour in the pituitary gland which leads to excessive secretion of a hormone called adrenocorticotrophic (ACTH), which in turn leads to increasing levels of cortisol in the body. Cortisol is a steroid hormone released by the adrenal glands and helps the body to deal wit…
- 骨・ミネラル代謝障害治療の世界市場（～2026年） Bone minerals are the inorganic compounds of the bone tissue that helps in strengthening the bones with its plate and globular structures. These minerals are formed from carbonated hydroxyapatite. Bone minerals are dynamic in living beings, it is continuously reabsorbed and build anew in the bone re…